It takes a lot of energy and time to have results on next rounds of clinical trials. The rest of the people are probably hard at work. I don't mind hearing oxytomodulin and blood clotting factors again besides growth hormone in the waiting period.
I don't have a problem with waiting and I don't have a problem with Havron talking to his doctor buddies. What I do have a problem with is a president who is our investor front man and getting paid a lot of money talking to doctors or sitting in Israel instead of living part time in NYC and London cold calling institutional investors. And if he is doing that, shame on him for not sharing that info with the current investors.
He is the reason the stock is where it is because other than repeaing what clearly has not worked to date, he has taken the position that there is nothing else he can do. If that is indeed true then what do we need him for? Nothing he can do = nothing.